 |
(6aR,10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | TMC Pharma Services Ltd |
Related Access Program
| |
(6aR,10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | TMC Pharma Services Ltd |